Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,767.60
(
-1.51%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.76
(
2.04%
)
Bitcoin
70,716.01
(
-0.74%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

madrose1

Send PM Follow Ignore
Followers 282
Posts 47139
Boards Moderated 10
Alias Born 04/07/2001

madrose1

Member Level

Re: madrose1 post# 168867

Monday, 10/28/2013 7:44:33 AM

Monday, October 28, 2013 7:44:33 AM

Post# of 257257
Clovis data competitive with AstraZeneca drug, says Citigroup
Citigroup views last night's data from Clovis (CLVS) as competitive with AstraZeneca's (AZN) AZD9291 in terms of efficacy and safety. Citi believes the lung cancer market is sizable enough to make both drugs big sellers and keeps a Buy rating on Clovis with a $109 price target. :theflyonthewall
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now